Find in Library

793 Combined administration of the dual A2aR/A2bR antagonist etrumadenant with a reduced chemotherapy regimen leads to enhanced tumor efficacy and survival

oleh: Daniel DiRenzo, Dana Piovesan, Sachie Marubayashi, Ferdie Soriano, Janine Kline, Matthew J Walters, Ruben Flores, Gonzalo Barajas